Abstract:Background: Mesenchymal stromal cells (MSCs) from different sources possess great therapeutic potential due to their immunomodulatory properties associated with allograft tolerance. However, a crucial role in this activity resides in extracellular vesicles (EVs) and signaling molecules secreted by cells. This study aimed to evaluate the immunomodulatory properties of donor and recipient MSCs isolated from adipose tissue (AD) or bone marrow (BM) and their EVs on kidney outcome in a rat kidney transplant model.Methods: The heterotopic-kidney-transplant Fisher-to-Lewis rat model (F-L) was performed to study mixed cellular and humoral rejection. After kidney transplantation, Lewis recipients were assigned to 10 groups; two control groups; four groups received autologous MSCs (either AD- or BM- MSC) or EVs (derived from both cell types); and four groups received donor-derived MSCs or EVs. AD and BM-EVs were purified by ultracentrifugation. Autologous cell therapies were administered three times intravenously; immediately after kidney transplantation, 4 and 8 weeks, whereas donor-derived cell therapies were administered once intravenously immediately after transplantation. Survival and renal function were monitored. Twelve weeks after kidney transplantation grafts were harvested, infiltrating lymphocytes were analyzed by flow cytometry and histological lesions were characterized.Results: Autologous AD- and BM-MSCs, but not their EVs, prolonged graft and recipient survival in a rat model of kidney rejection. Autologous AD- and BM-MSCs significantly improved renal function during the first 4 weeks after transplantation. The amelioration of graft function could be associated with an improvement in tubular damage, as well as in T, and NK cell infiltration. On the other side, the application of donor-derived AD-MSC was harmful, and all rats died before the end of the protocol. AD-EVs did not accelerate the rejection. Contrary to autologous MSCs results, the single dose of donor-derived BM-MSCs is not enough to ameliorate kidney graft damage.Conclusion: EVs treatments did not exert any benefit in our experimental settings. In the autologous setting, BM-MSCs prompted as a potentially promising therapy to improve kidney graft outcomes in rats with chronic mixed rejection. In the donor-derived setting, AD-MSC accelerated progression to end-stage kidney disease. Further experiments are required to adjust timing and dose for better long-term outcomes.

Extracellular Vesicles Released by Adipose Tissue-Derived Mesenchymal Stromal/stem Cells from Obese Pigs Fail to Repair the Injured Kidney.

Metabolic Syndrome Alters the Cargo of Mitochondria-Related Micrornas in Swine Mesenchymal Stem Cell-Derived Extracellular Vesicles, Impairing Their Capacity to Repair the Stenotic Kidney

P0146MESENCHYMAL STEM CELLS AND THEIR EXTRACELLULAR VESICLES PROGENY DECREASE RENAL INJURY IN EXPERIMENTAL SWINE RENAL ARTERY STENOSIS THROUGH DIFFERENT MECHANISMS

Mesenchymal Stem/stromal Cells and Their Extracellular Vesicle Progeny Decrease Injury in Post-Stenotic Swine Kidney Through Different Mechanisms.

Selective Intrarenal Delivery of Mesenchymal Stem Cell-Derived Extracellular Vesicles Attenuates Myocardial Injury in Experimental Metabolic Renovascular Disease.

Mesenchymal Stem Cell–derived Extracellular Vesicles Attenuate Kidney Inflammation

Impact of Mesenchymal Stromal Cells and Their Extracellular Vesicles in a Rat Model of Kidney Rejection

Obesity blunts the effect of mesenchymal stem cell-derived extracellular vesicles

Metabolic Syndrome Interferes with Packaging of Proteins within Porcine Mesenchymal Stem Cell-Derived Extracellular Vesicles

The Metabolic Syndrome Alters The Mirna Signature Of Porcine Adipose Tissue-Derived Mesenchymal Stem Cells

Metabolic Syndrome Induces Release of Smaller Extracellular Vesicles from Porcine Mesenchymal Stem Cells

Autologous Extracellular Vesicles Attenuate Cardiac Injury in Experimental Atherosclerotic Renovascular Disease More Effectively Than Their Parent Mesenchymal Stem/Stromal Cells

Mesenchymal Stem Cell–Derived Extracellular Vesicles Induce Regulatory T Cells to Ameliorate Chronic Kidney Injury

Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles Elicit Better Preservation of the Intra-Renal Microvasculature Than Renal Revascularization in Pigs with Renovascular Disease

IL-10 Partly Mediates the Ability of MSC-derived Extracellular Vesicles to Attenuate Myocardial Damage in Experimental Metabolic Renovascular Hypertension.

Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Alleviate Renal Ischemic Reperfusion Injury and Enhance Angiogenesis in Rats.

Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs

The Micro-RNA Cargo of Extracellular Vesicles Released by Human Adipose Tissue-Derived Mesenchymal Stem Cells Is Modified by Obesity

Augmented Efficacy of Exogenous Extracellular Vesicles Targeted to Injured Kidneys

Integrated Transcriptomic And Proteomic Analysis Of The Molecular Cargo Of Extracellular Vesicles Derived From Porcine Adipose Tissue-Derived Mesenchymal Stem Cells

Comparative Proteomic Analysis of Extracellular Vesicles Isolated from Porcine Adipose Tissue-Derived Mesenchymal Stem/stromal Cells.